M8G-28357-36026
3 vaccinations
2 coded responses
38 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 766 / TX
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-04-11
- 2021-04-12
-
2021-04-13
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Headache · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — day 7, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-10-09
Dose 3 — Pfizer-BioNTech
-
2021-10-09
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-11
- 2021-10-12
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2022-01-08
-
2022-04-09
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — day 7, dose 2
Systemic reaction (other): Sore throat
Release 11 — 6 months, dose 3
Symptoms: Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release